AI assistant
Telecure Technologies Inc. — Regulatory Filings 2021
Sep 2, 2021
47777_rns_2021-09-01_a03900ea-74bd-4ca8-bf3f-2e86d57c5828.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
FORM 51-102F3 MATERIAL CHANGE REPORT
Item 1 Name and Address of Company
Telecure Technologies Inc. (the “ Company ” or " TeleCure ") 1930 - 1177 West Hastings Street Vancouver, British Columbia Canada V6E 3T4
Item 2: Date of Material Change
August 31, 2021
Item 3 News Release
The Company disseminated a news release announcing the material change described herein through the news dissemination services of Accesswire on August 31, 2021, and a copy was subsequently filed on SEDAR.
Item 4 Summary of Material Change
The Company announced it has commenced trading on the Canadian Securities Exchange under the ticker symbol, TELE.
Item 5 Full Description of Material Change
5.1 Full Description of Material Change
The Company announced it has commenced trading on the Canadian Securities Exchange under the ticker symbol, TELE.
TeleCure Technologies
CallingDr. is a complete telemedicine solution connecting doctors and caregivers with patients using any device, on demand, when, where, and how the patient chooses. Provides and patients can interact with each other under HIPPAA & HITECH compliance standards. The platform is customizable and can be built to suit the needs of individual practices, clinics, or long-term care centers.
FindingDr. is an online appointment booking service that allows patients to find and book appointments with physicians and healthcare providers. The platform allows practices to gain exposure and access new patients through ease of use and access.
TeleCure’s platforms are combined with a large set of patient monitoring and examination devices including its very own Intraoral Camera designed for doctors and dentists to view inside of a patients, oral cavity in real-time. CallingDr. integrates with a variety of devices such as stethoscopes, blood pressure monitors, and other wearable devices.
Management Team
Adnan Malik – Chief Executive Officer, Director, Board Member – Mr. Malik is a serial entrepreneur with several US patents published and in the works. Mr. Malik began his career with Seagate Technology, followed by Veritas Software and Symantec. Mr. Malik co-founded Physicians EMR and sold his stake in
the company in 2016 after successfully launching an ambulatory electronic medical record product with the Office of the National Coordinator for Health Information Technology certification. Mr. Malik has a Master’s of Science in Electrical & Computer Engineering, with over 24 years of management experience of technical teams globally.
Josh Rosenberg – Chief Operations Officer, Director, – Josh Rosenberg is a former Executive in the CocaCola system, where he led in his position as Vice President of Sales of the unattended retail and convenience services segment of the Coca-Cola Company after heading in his position as Channel and Product Commercialization of their food service division, their $700 million, multi‐channel business. During Josh’s six years in his position as Chairman and Chief Executive Officer, Accent Food Services grew top line revenue by more than six-fold from $38 million to $155 million, expanded operations to cover 11 U.S. states from being a single state operator, and grew to encompass more than 600 associates (from 179), 30,000+ customers (from 14,000), and the service of more than 750,000 customers. Since leaving Accent Josh has serviced both private and public boards, executive consulting, and fundraising.
Kashif Akram – Chief Technical Officer, Director, Board Member – Mr. Akram is an entrepreneur and an information technology professional with demonstrated expertise in the fields of healthcare, education, innovative payment solutions and e-Government. Mr. Akram has vast experience in leading and structuring multi-million dollar portfolios and in developing and successfully delivering highly complex software projects. Mr. Akram holds a Bachelor of Computer Science (Honours) from Hamdard University.
5.2 Disclosure for Restructuring Transactions
Not applicable
Item 6 Reliance on subsection 7.1(2) of National Instrument 51-102
This report is not being filed on a confidential basis.
Item 7 Omitted Information
There are no significant facts required to be disclosed herein which have been omitted.
Item 8 Executive Officer
For further information, please contact Adnan Malik, Chief Executive Officer of the Company, at 604-3983432.
Item 9 Date of Report
September 1, 2021